Influenza Virus Genomic Surveillance, Arizona, USA, 2023-2024
- PMID: 38793574
- PMCID: PMC11125580
- DOI: 10.3390/v16050692
Influenza Virus Genomic Surveillance, Arizona, USA, 2023-2024
Abstract
Influenza viruses are constantly evolving and are therefore monitored worldwide in the hope to reduce the burden of disease by annual updates to vaccine recommendations. We conducted genomic sequencing of 110 influenza A and 30 influenza B viruses from specimens collected between October 2023 and February 2024 in Arizona, USA. We identified mutations in the hemagglutinin (HA) antigenic sites as well as the neuraminidase (NA) gene in our samples. We also found no unique HA and NA mutations in vaccinated yet influenza-infected individuals. Real-time genomic sequencing surveillance is important to ensure influenza vaccine effectiveness.
Keywords: Arizona; genomic surveillance; influenza virus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Huddleston J., Barnes J.R., Rowe T., Xu X., Kondor R., Wentworth D.E., Whittaker L., Ermetal B., Daniels R.S., McCauley J.W., et al. Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. Elife. 2020;9:e60067. doi: 10.7554/eLife.60067. - DOI - PMC - PubMed
-
- Rolfes M.A., Foppa I.M., Garg S., Flannery B., Brammer L., Singleton J.A., Burns E., Jernigan D., Olsen S.J., Bresee J., et al. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza Other Respir. Viruses. 2018;12:132–137. doi: 10.1111/irv.12486. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical